Mohideen Pharis 4
4 · DBV Technologies S.A. · Filed Nov 25, 2025
Insider Transaction Report
Form 4
Mohideen Pharis
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2025-11-20$2.88/sh−6,496$18,708→ 103,153 total - Award
Employee Stock Option (right to buy)
2025-11-21+253,000→ 253,000 totalExercise: $2.90Exp: 2035-11-21→ Ordinary Shares (253,000 underlying) - Award
Ordinary Shares
2025-11-21+44,000→ 145,529 total - Sale
Ordinary Shares
2025-11-21$2.77/sh−1,624$4,498→ 101,529 total
Footnotes (6)
- [F1]The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
- [F2]Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
- [F3]This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15268 to EURO 1.00 as of November 20, 2025.
- [F4]This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.
- [F5]Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.
- [F6]The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.